- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04623918
Iron-Biofortified Rice Intervention in the Philippines
Randomized Trial of Iron-Biofortified Rice in Women in the Philippines
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Iron deficiency is the most prevalent nutritional deficiency globally, with the highest burden in women of reproductive age and children. In this randomized controlled trial, 317 women aged 18-45 years living in convents in the greater Manila area, Philippines, were fed meals using either biofortified or commercially available rice for all meals, 7 days a week, for 9 months. Women living in convents in the greater Manila area were recruited for this study. These women represent a segment of the population at high risk for iron deficiency, consume large quantities of rice, and all of their meals are prepared and consumed in common kitchen and dining areas, respectively.
The investigators hypothesized that daily consumption of iron-biofortified rice (IR68144-2B-2-2-3) would improve hemoglobin, serum ferritin, and total body iron in 9 months, compared to control rice. In order to examine this hypothesis, the investigators conducted a randomized efficacy trial of iron-biofortified rice and iron status in among women living in convents in the greater area of Manila, Philippines for 9 months.
The objective of this randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified rice on iron status in women, compared to non-biofortified rice.
The long-term goal of this study is to determine if iron bio-fortification of rice is an efficacious and potentially effective strategy to improve iron status of at-risk populations in resource-limited settings.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Laguna
-
Los Baños, Laguna, Philippines, 4031
- University of the Philippines
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women (18-45 years old) living in convents in the greater Manila area
- Hb ≥10.5 g/dL
Exclusion Criteria:
- Current or history of gastrointestinal or hematological disorders
- Taking iron supplements or medications that could interfere with hematopoiesis or dietary iron absorption
- Hb <10.5 g/dL
- Women expressed uncertainty in their ability to participate for the full (9 month) trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Iron-biofortified rice
Iron-biofortified rice (IR68144-2B-2-2-3)
|
Iron-biofortified rice (IR68144-2B-2-2-3)
|
|
Active Comparator: Control rice
Control rice (C4)
|
Control rice (C4), identical in appearance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in serum ferritin
Time Frame: 9 months
|
Serum ferritin (SF)
|
9 months
|
|
Change in sTfR
Time Frame: 9 months
|
Soluble transferrin receptor (sTfR)
|
9 months
|
|
Change in TBI
Time Frame: 9 months
|
Total body iron (TBI)
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hemoglobin among women who were anemic at baseline
Time Frame: 9 months
|
Changes in hemoglobin (Hb) in women who were anemic at baseline
|
9 months
|
|
Changes in SF among women who were non-anemic at baseline
Time Frame: 9 months
|
Changes in SF among women who were non-anemic at baseline
|
9 months
|
|
Changes in sTfR among women who were non-anemic at baseline
Time Frame: 9 months
|
Changes in sTfR among women who were non-anemic at baseline
|
9 months
|
|
Changes in TBI among women who were non-anemic at baseline
Time Frame: 9 months
|
Changes in TBI among women who were non-anemic at baseline
|
9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jere Haas, Cornell University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Haas2005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron-deficiency
-
Pennington Biomedical Research CenterCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
Tampere University HospitalTampere UniversityRecruitingIron Deficiency | Iron Deficiency Anaemia in Childbirth | Iron Status | Iron Deficiency in Pregnancy | Iron Deficiency Anemia in PregnancyFinland
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Antalya Training and Research HospitalCompletedIron Deficiency Anemia | Iron Deficiency Anemia TreatmentTurkey
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
CMH Multan Institute of Medical SciencesCompletedPregnancy | Iron Deficiency Anemia (IDA)Pakistan
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Syracuse University; Liverpool... and other collaboratorsCompletedIron-deficiency | Iron-deficiency AnemiaGhana
-
Société des Produits Nestlé (SPN)CompletedIron-deficiency | Anemia | Iron Deficiency AnemiaPhilippines
-
Swiss Federal Institute of TechnologyUniversity of MalawiCompletedIron-deficiency | Iron Deficiency AnemiaMalawi, Switzerland
Clinical Trials on Iron-biofortified rice
-
Instituto de Investigacion Nutricional, PeruUniversity of East Anglia; Quadram Institute BioscienceCompleted
-
University of AberdeenRecruitingIron Biomarkers/StatusUnited Kingdom
-
Pennington Biomedical Research CenterThe Wright Group in Crowley, LACompletedIron Deficiency AnemiaUnited States
-
Swiss Federal Institute of TechnologyUniversity of ZurichCompleted
-
Swiss Federal Institute of TechnologyUniversité d'Abomey-CalaviCompletedIron Deficiency | BiofortificationBenin
-
Federal University of Minas GeraisFundação de Amparo à Pesquisa do estado de Minas GeraisCompletedAnemia | Iron Deficiency AnemiaBrazil
-
International Centre for Diarrhoeal Disease Research...RecruitingMalnourished ChildrenBangladesh
-
Cornell UniversityInstituto Nacional de Salud Publica, MexicoCompleted
-
Cornell UniversityArogyavaram Medical Centre; SNDT Women's UniversityActive, not recruitingIron Deficiency | Vitamin A Deficiency | Zinc DeficiencyIndia
-
University of Santo TomasEnrolling by invitationDyslipidemias | Overweight or Obesity | Hyperglycaemia (Non Diabetic)Philippines